Literature DB >> 16127427

Immortalization of pancreatic stellate cells as an in vitro model of pancreatic fibrosis: deactivation is induced by matrigel and N-acetylcysteine.

Ralf Jesnowski1, Daniel Fürst, Jörg Ringel, Ying Chen, Andrea Schrödel, Jörg Kleeff, Armin Kolb, Wolfgang D Schareck, Matthias Löhr.   

Abstract

Tissue fibrosis is one of the characteristics of chronic pancreatitis and pancreatic adenocarcinoma. Activated pancreatic stellate cells (PSC) play a central role in this process. However, analysis of the molecular mechanisms leading to PSC activation is hampered by the lack of an established human PSC line. To overcome this problem, we immortalized and characterized primary human PSC. The cells were isolated by the outgrowth method and were immortalized by transfection with SV40 large T antigen and human telomerase (hTERT). Primary human PSC served as controls. An immortalized line, RLT-PSC, was analyzed for the expression of stellate cell markers. Moreover, the effects of transforming growth factor beta 1(TGFbeta1) or platelet-derived growth factor stimulation and of cultivation on basement membrane components or N-acetylcysteine (NAC) treatment on gene and protein expression and proliferation were analyzed. Immortal RLT-PSC cells retained the phenotype of activated PSC proven by the expression of alpha-smooth muscle actin (alphaSMA), vimentin, desmin and glial fibrillary acidic protein (GFAP). TGFbeta1 treatment upregulated the expression of alphaSMA, collagen type I (Col I), fibronectin and TGFbeta1. Incubation of RLT-PSC cells and primary human activated PSC on Matrigel plus NAC treatment resulted in a deactivated phenotype as evidenced by a decrease of alphaSMA, connective tissue growth factor and Col I expression and by a decreased proliferation of the cells. Moreover, this treatment restored the ability of the cells to store vitamin A in cytoplasmic vesicles. In conclusion, we have established an immortal pancreatic stellate cell line, without changing the characteristic phenotype. Importantly, we were able to demonstrate that besides soluble factors, the matrix surrounding PSC plays a pivotal role in the maintenance of the activation process of PSC. Cultivation of activated PSC on a reconstituted basement membrane plus treatment with NAC was able to deactivate the cells, thus pointing to the possibility of an antifibrosis therapy in chronic pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16127427     DOI: 10.1038/labinvest.3700329

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  71 in total

1.  Constitutive K-RasG12D activation of ERK2 specifically regulates 3D invasion of human pancreatic cancer cells via MMP-1.

Authors:  Gregory P Botta; Mauricio J Reginato; Maximilian Reichert; Anil K Rustgi; Peter I Lelkes
Journal:  Mol Cancer Res       Date:  2011-12-08       Impact factor: 5.852

2.  Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry.

Authors:  Angela Y Wehr; Wei-Ting Hwang; Ian A Blair; Kenneth H Yu
Journal:  J Proteome Res       Date:  2012-02-15       Impact factor: 4.466

3.  Analysis of the human pancreatic stellate cell secreted proteome.

Authors:  Angela Y Wehr; Emma E Furth; Vineet Sangar; Ian A Blair; Kenneth H Yu
Journal:  Pancreas       Date:  2011-05       Impact factor: 3.327

Review 4.  The pancreatic stellate cell: a star on the rise in pancreatic diseases.

Authors:  M Bishr Omary; Aurelia Lugea; Anson W Lowe; Stephen J Pandol
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 5.  Pancreatic cancer organotypics: High throughput, preclinical models for pharmacological agent evaluation.

Authors:  Stacey J Coleman; Jennifer Watt; Prabhu Arumugam; Leonardo Solaini; Elisabeta Carapuca; Mohammed Ghallab; Richard P Grose; Hemant M Kocher
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

6.  DYRK1B regulates Hedgehog-induced microtubule acetylation.

Authors:  Rajeev Singh; Philipp Simon Holz; Katrin Roth; Anna Hupfer; Wolfgang Meissner; Rolf Müller; Malte Buchholz; Thomas M Gress; Hans-Peter Elsässer; Ralf Jacob; Matthias Lauth
Journal:  Cell Mol Life Sci       Date:  2018-10-13       Impact factor: 9.261

7.  Functional analysis of LOXL2 in pancreatic carcinoma.

Authors:  Felix Rückert; Peer Joensson; Hans-Detlev Saeger; Robert Grützmann; Christian Pilarsky
Journal:  Int J Colorectal Dis       Date:  2009-12-09       Impact factor: 2.571

8.  Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation.

Authors:  Julie Jacobs; Vanessa Deschoolmeester; Karen Zwaenepoel; Tal Flieswasser; Christophe Deben; Jolien Van den Bossche; Christophe Hermans; Christian Rolfo; Marc Peeters; Olivier De Wever; Filip Lardon; Vasiliki Siozopoulou; Evelien Smits; Patrick Pauwels
Journal:  Oncoimmunology       Date:  2018-03-19       Impact factor: 8.110

9.  Organotypic culture model of pancreatic cancer demonstrates that stromal cells modulate E-cadherin, beta-catenin, and Ezrin expression in tumor cells.

Authors:  Fieke E M Froeling; Tariq A Mirza; Roger M Feakins; Angela Seedhar; George Elia; Ian R Hart; Hemant M Kocher
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

Review 10.  [Autoimmune pancreatitis].

Authors:  A Schneider; J M Löhr
Journal:  Internist (Berl)       Date:  2009-03       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.